Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Disease Susceptibility

• Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency
• Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma
• Eradication of H. Pylori Infection With Moxifloxacin
• Clarithromycin Susceptibility-Guided Treatment of Helicobacter Pylori Infection
• Short Term Sirolimus Treatment and MRI of the Brain
• Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection
• Susceptibility Testing Guided Versus Empirical Therapy for Refractory H. Pylori Infection
• Single Dose and Multiple Dose Study to Assess Safety and Tolerability of LOU064
• PTX3-targeted Antifungal Prophylaxis
• Efficacies of Antimicrobial Susceptibility-Guided Versus Empirical Therapy for Rescue Treatment of Helicobacter Pylori Infection
• Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication.
• Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the Rescue Treatment of Helicobacter Pylori Infection
• Genotypic Resistance Guided Versus Susceptibility Testing Guided Therapy for the First-line Eradication of H. Pylori
• Effect of Antibiotics on Penile Microbiome and HIV Susceptibility Study in Ugandan Men
• Efficacy of the Use of Genetic Markers in the Choice of the Pharmacological Treatment of Smoking (GENTSMOKE)
• Mutation Scores and Differential Protein Evaluating Efficacy in Adjuvant Chemotherapy in HER2(-) Luminal B Breast Cancer
• Optimal Management of HIV Infected Adults at Risk for Kidney Complications in Nigeria
• Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori Treatment
• Antimicrobial Susceptibility Testing Guided Antibiotic Selection Strategies in Salvage Helicobacter Pylori Treatment
• Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa
• Clinical Validation of a Molecular Test for Ciprofloxacin-Susceptibility in Neisseria Gonorrhoeae
• Effect of Schistosomiasis Mansoni on HIV Susceptibility and Female Genital Immunology
• Development of Treatment Algorithm for Eradication of Helicobacter Pylori Based on Antibiotic Susceptibility Test
• Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome
• Effect of Bacterial Vaginosis on HIV Susceptibility and Female Genital Immunology
• Optimization of MDR-TB Treatment Regimen Based on the Molecular Drug Susceptibility Results of Pyrazinamide
• ATG Versus Basiliximab in Kidney Transplant Displaying Low Immunological Risk But High Susceptibility to DGF
• The Pharmacokinetics of Extended Duration High-dose Cefixime for the Decreased Susceptibility of Neisseria Gonorrhoeae: A Phase I Pilot Study
• Brain Networks and Addiction Susceptibility
• BRCA1/2 and Effect of Mifepristone on the Breast
• Antimalarial Drug Susceptibility and Molecular Characterization of Plasmodium Vivax Isolates in Vietnam
• Clopidogrel Pharmacogenomics Project
• The Efficacy of Susceptibility Test -Driven Sequential Therapy as the Third Line Therapy for Refractory Helicobacter Pylori Infection
• A Clinico-Bacteriological Study and Effect of Stress Ulcer Prophylaxis on Occurrence of Ventilator Associated Pneumonia
• Modulation by Sex Hormones of Inflammation and Susceptibility to Pseudomonas Aeruginosa in Cystic Fibrosis Airways
• Susceptibility of Motor-Evoked Potentials to Varying Targeted Blood Levels of Dexmedetomidine
• Clinical Investigation of In-vivo Susceptibility of P.Falciparum to Artesunate in Western Cambodia
• Mycoplasma Genitalium Antibiotic Susceptibility and Treatment (MEGA)
• Clinical Utility Of Genetic Screening For HLA-B*5701, On Susceptibility To Abacavir Hypersensitivity
• Genetic Susceptibility to Ozone in Mild Asthmatic Volunteers
• Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)
• A Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate (U-87201E), Zidovudine (AZT), and Didanosine (ddI)